EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Comorbidities in psoriatic arthritis: a systematic review and meta-analysis

Sonal Gupta, Zoe Syrimi, David M Hughes, Sizheng Steven Zhao

Rheumatology International · 2021-02 · 41 (2) · 275-284

DOI: 10.1007/s00296-020-04775-2 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Rheumatology International, online erschienen am 09.01.2021. Verfasst von Sonal Gupta und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of Liverpool, Liverpool, UK. Hauptthemen laut MEDLINE: Quality of Life. Die Arbeit wurde bisher 173-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aims of this systematic review and meta-analysis were to: (1) describe the prevalence of commonly reported comorbidities in psoriatic arthritis (PsA), (2) compare the incidence and/or prevalence of comorbidities between PsA and control populations; and (3) examine the impact of comorbidities on PsA outcomes. We systematically searched Medline, PubMed, Scopus, and Web of Science using a predefined protocol in accordance with PRISMA guidelines. Studies reporting only one comorbidity, or a few closely related diseases within one organ system, were excluded. Where possible, meta-analysis was performed using random-effects models. We included 39 studies amounting to over 152 thousand PsA patients. We performed meta-analysis for the prevalence of 21 commonly reported comorbidities. The most prevalent comorbidities were hypertension (pooled prevalence 34%), metabolic syndrome (29%), obesity (27%), hyperlipidaemia (24%) and any cardiovascular diseases (19%). Eleven studies consistently showed higher prevalence of comorbidities in PsA than controls. Five studies showed that comorbid patients had more severe disease, poorer quality of life, and increased discontinuation of treatment. Comorbidities, particularly cardiometabolic disorders, were highly prevalent in PsA and more common than in healthy controls. Comorbidities were associated with adverse disease features, but more research is needed on their impact on longitudinal outcomes such as treatment response, work productivity and mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeArthritis, PsoriaticCardiovascular DiseasesChronic DiseaseComorbidityDepressionFemaleHumansMaleMetabolic SyndromePrevalence

Stichwörter der Autor:innen

ComorbidityMeta-analysisMultimorbidityPsoriatic arthritisSystematic review

Autor:innen und Institutionen

  • School of Medicine, University of Liverpool, Liverpool, UK.
  • Department of Medicine, Liverpool University Hospitals, Liverpool, UK.
  • Department of Health Data Science, Institute of Population Health, University of Liverpool, Liverpool, UK.
  • Musculoskeletal Biology, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, L69 3GA, UK. s.zhao8@liverpool.ac.uk.

Zitieren

APA

Gupta, S., Syrimi, Z., Hughes, D. M., & Zhao, S. S. (2021). Comorbidities in psoriatic arthritis: a systematic review and meta-analysis. Rheumatology International, 41(2), 275-284. https://doi.org/10.1007/s00296-020-04775-2

Vancouver

Gupta S, Syrimi Z, Hughes DM, Zhao SS. Comorbidities in psoriatic arthritis: a systematic review and meta-analysis. Rheumatology International. 2021;41(2):275-284. doi:10.1007/s00296-020-04775-2

BibTeX
@article{Gupta2021,
  author = {Gupta, Sonal and Syrimi, Zoe and Hughes, David M and Zhao, Sizheng Steven},
  title = {Comorbidities in psoriatic arthritis: a systematic review and meta-analysis},
  journal = {Rheumatology International},
  year = {2021},
  volume = {41},
  number = {2},
  pages = {275--284},
  doi = {10.1007/s00296-020-04775-2}
}
Kostenlos starten →